Yan, Wei <br/><br/>
MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.  [electronic resource] 

 -  Oncotarget  May 2015 
 - 11676-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.3258  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Asian People<br/>Biomarkers, Tumor--genetics<br/>Brain Neoplasms--drug therapy<br/>China--epidemiology<br/>Cluster Analysis<br/>Dacarbazine--analogs & derivatives<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--metabolism<br/>Female<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Neoplastic<br/>Glioblastoma--drug therapy<br/>Humans<br/>Isocitrate Dehydrogenase--genetics<br/>Kaplan-Meier Estimate<br/>Ki-67 Antigen--metabolism<br/>Male<br/>MicroRNAs--genetics<br/>Middle Aged<br/>Mutation<br/>Oligonucleotide Array Sequence Analysis<br/>Predictive Value of Tests<br/>Real-Time Polymerase Chain Reaction<br/>Reproducibility of Results<br/>Temozolomide<br/>Treatment Outcome